Ataxin 2 (ATXN2) (Middle Region) Peptid
Kurzübersicht für Ataxin 2 (ATXN2) (Middle Region) Peptid (ABIN973648)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-ATXN2 antibody (Catalog #: ARP38210_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Ataxin 2 (ATXN2)
-
Hintergrund
-
The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA ty
Alias Symbols: ATX2, FLJ46772, SCA2, TNRC13
Protein Interaction Partner: A2BP1,ACTN1,ACTN2,ATXN1,BAT3,BIN1,CHGB,GFI1B,IDH3B,KIAA1279,LCP1,NCOA4,PABPC1,PLS3,SH3GL2,SH3GL3,TDRD7,ZNRD1,CD247,CHGB,VHL
Protein Size: 1313 -
Molekulargewicht
- 140 kDa
-
Gen-ID
- 6311
-
NCBI Accession
- NM_002973, NP_002964
-
UniProt
- Q99700
Target
-